Associated Banc-Corp’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
JFG
Associated Banc-Corp's XBI Position: Q2 2026 in Review
Associated Banc-Corp reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 2.4% in Q2 2026, selling an estimated $21.6K and leaving 6,639 shares worth $1.05M. The position accounts for 0.02% of the portfolio, ranked #216.
Associated Banc-Corp first reported a position in XBI in Q2 2022 and has held it in 17 quarters since. The position peaked at $1.2M in Q3 2024. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.
- Associated Banc-Corp held 6,639 shares of State Street SPDR S&P Biotech ETF worth $1.05M as of Q2 2026.
- Associated Banc-Corp sold 160 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $21.6K.
- State Street SPDR S&P Biotech ETF made up 0.02% of Associated Banc-Corp's portfolio in Q2 2026, its #216 holding.
- Associated Banc-Corp first reported a position in State Street SPDR S&P Biotech ETF in Q2 2022 and has held it in 17 quarters since.
- Associated Banc-Corp's State Street SPDR S&P Biotech ETF position peaked at $1.2M in Q3 2024.
- 933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.
Based on Associated Banc-Corp's 13F filing for Q2 2026, filed 31 Jul 2026.